Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

4 terminated/withdrawn out of 32 trials

Success Rate

77.8%

-8.7% vs industry average

Late-Stage Pipeline

9%

3 trials in Phase 3/4

Results Transparency

21%

3 of 14 completed trials have results

Key Signals

3 recruiting3 with results

Enrollment Performance

Analytics

N/A
10(52.6%)
Phase 1
3(15.8%)
Phase 3
2(10.5%)
Phase 2
2(10.5%)
Early Phase 1
1(5.3%)
Phase 4
1(5.3%)
19Total
N/A(10)
Phase 1(3)
Phase 3(2)
Phase 2(2)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (32)

Showing 20 of 32 trials
NCT03627923Active Not Recruiting

Personalizing Mediterranean Diet in Children.

Role: collaborator

NCT07376850Not ApplicableNot Yet Recruiting

Time in rANge vs. Time in nOrmal Glycemia for Better Glycemic Control

Role: collaborator

NCT07321171Not ApplicableRecruiting

Stepped-Care for Suicidal Youth and Children

Role: collaborator

NCT03681652Recruiting

Post-Operative Crohn's Disease Outcome in Children

Role: lead

NCT05882175Recruiting

Prospective Validation of the OHI Index

Role: collaborator

NCT06921993Not ApplicableNot Yet Recruiting

Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia

Role: collaborator

NCT03026582Completed

Intestinal Ultrasound in Pediatric Inflammatory Bowel Disease

Role: lead

NCT02745457Completed

Body Composition in Children With Inflammatory Bowel Disease

Role: lead

NCT02893670Not ApplicableCompleted

Tailored Transition for IBD Adolescents

Role: lead

NCT04717115Unknown

Genotype/Phenotype Correlation With Focus on Lung Function in Primary Ciliary Dyskinesia (PCD)

Role: collaborator

NCT02277223Phase 3Withdrawn

Curcumin in Pediatric Ulcerative Colitis

Role: lead

NCT03209232Not ApplicableTerminated

Infliximab Accelerated Induction in Moderate to Severe Pediatric UC

Role: lead

NCT02256462Phase 4Completed

Pediatric Crohn's Disease AdalImumab Level-based Optimization Treatment (PAILOT) Trial

Role: lead

NCT02991443Not ApplicableCompleted

Mindfulness Based Stress Reduction for Parents of Children With IBD

Role: lead

NCT04949308Unknown

Nasal Nitric Oxide Across Mutations in Primary Ciliary Dyskinesia

Role: collaborator

NCT03040414Not ApplicableCompleted

Fuzzy Logic Automated Insulin Regulation

Role: collaborator

NCT01484457Early Phase 1Completed

Controlled Insulin Delivery: Combining Technology With Treatment

Role: collaborator

NCT01701479Phase 1Unknown

Long Term Continuous Infusion ch14.18/CHO Plus s.c. Aldesleukin (IL-2)

Role: collaborator

NCT04254991Unknown

A Controlled, Blinded Study to Validate the Diagnostic Accuracy and Assess the Clinical Utility of a Host-response Based Diagnostic Tool for Distinguishing Between Bacterial and Viral Etiologies in Pediatric Patients Presenting to the ED With Suspicion of Acute Infection

Role: collaborator

NCT02929953Completed

Prematurity Prevalence Among T1D Patients and Its Characteristics Compared With Premature-born Non-diabetic Patients

Role: collaborator